Screener
Revvity RVTY Diagnostics — Restructuring and Other Costs (Income)
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Revvity in its filing.
Tagged under the XBRL concept us-gaap:RestructuringCosts.
The source filing: Revvity’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000031791-26-000019
FAQ
- What is Revvity's diagnostics — restructuring and other costs (income)?
- Revvity (RVTY) reported diagnostics — restructuring and other costs (income) of $7.55M in Q1 2026.
- How has Revvity's diagnostics — restructuring and other costs (income) changed year-over-year?
- Revvity's diagnostics — restructuring and other costs (income) increased by 5495.6% year-over-year, from $135K to $7.55M.
- What does diagnostics — restructuring and other costs (income) mean?
- Captures non-recurring expenses or income related to organizational changes, such as facility consolidations, workforce reductions, or strategic realignments within the diagnostics segment. These costs are typically excluded from core operating performance to show underlying business trends.
Ask your AI about Revvity's diagnostics — restructuring and other costs (income).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude